CCM
MACK

Cadence Capital Management’s Merrimack Pharmaceuticals, Inc. MACK Stock Holding History

Cadence Capital Management’s Portfolio MACK Stock Details MACK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-41,773
Closed -$4.06M – 688
2015
Q2 		$4.06M Buy
41,773
+1,893
+5% +$184K 0.23% 122
2015
Q1 		$3.73M Sell
39,880
-4,454
-10% -$416K 0.23% 118
2014
Q4 		$3.94M Buy
44,334
+19,815
+81% +$1.76M 0.23% 129
2014
Q3 		$1.69M Buy
+24,519
New +$1.69M 0.09% 269